mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.001 |
mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.001 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
apicidin |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |